CAR-T Cell Therapy

Dr. Sikander Ailawadhi says physicians are identifying, monitoring and eliminating blood cancer earlier thanks to new treatments.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

Mayo Clinic researchers are collaborating to develop CAR-T cell therapy for solid tumors in thyroid cancer.

After Sylvester Pinckney's lymphoma returned, chimeric antigen receptor-T cell therapy at Mayo Clinic put his cancer back in remission.

After receiving CAR-T cell therapy at Mayo Clinic, Welsh-born John Cadwallader achieved remission and found new hope. He now receives care in the U.K. and is monitored by Mayo in the U.S. and London.

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.

After receiving CAR-T cell therapy for chronic lymphocytic leukemia through a clinical trial at Mayo Clinic, Jon Stahlecker is cancer free and feeling good.

The story of Brooke Michael's journey to successful CAR-T cell therapy treatment after being diagnosed with primary B-cell lymphoma at 17.